Temporary effect of arsenic trioxide treatment of refractory extragonadal germ cell cancer

Author： Kälkner Karl Mikael   Ullén Anders   Wersäll Peter   Cohn-Cedermark Gabriella  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.46, Iss.6, 2007-01, pp. : 862-863

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment outcome of patients with extragonadal nonseminomatous germ cell tumors: the Saitama Cancer Center experience

By Fukui Naotaka   Kohno Yusuke   Ishioka Jun-Ichiro   Fukuda Hiroshi   Kageyama Yukio   Higashi Yotsuo  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 731-734

Springer Publishing Company

Access to resources Recommend Favorite

MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24

By Cao Yan  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 179-188

Springer Publishing Company

Access to resources Recommend Favorite

Utilization of arsenic trioxide as a treatment of cisplatin-resistant non-small cell lung cancer PC-9/CDDP and PC-14/CDDP cells

By          

Oncology Letters, Vol. 10, Iss. 2, 2015-01 ,pp. : 805-809

Spandidos Publications

Access to resources Recommend Favorite

Metachronous gonadal and extragonadal primaries, or late relapse of germ cell tumor?

By Daniel C.   Fizazi K.   Culine S.   Zelek L.   Wibault P.   Theodore C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 2, 2001-03 ,pp. : 49-52

Elsevier

Access to resources Recommend Favorite

Primary extragonadal germ cell tumor: A case report on prostate seminoma

By                    

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2323-2326

Spandidos Publications

Access to resources Recommend Favorite